Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-24T14:44:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-25T14:54:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding/operating-status notice from the page.
    Difference
    0.3%
    Check dated 2025-11-18T07:33:37.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added Cali, Colombia as a study site and removed Santiago de Cali, Colombia from the locations. This updates the study's site list and may affect participant access and logistics.
    Difference
    0.4%
    Check dated 2025-10-27T21:10:33.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Major update: adds an operating-status notice and updates version to v3.2.0; removes the Follicular lymphoma resource (from GRDIC).
    Difference
    4%
    Check dated 2025-10-06T08:24:03.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T04:55:46.000Z thumbnail image

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.